Acute Myelogenous Leukemia in Remission

Publisher Website
Google Scholar
Abstract
To the Editor: The letter by Blume and his colleagues provided new interesting information on the role of bone-marrow transplantation in acute leukemia (July 9 issue).1 However, only four patients with acute myeloid leukemia received transplants during a first remission in the series on which Blume et al. reported,2 and although these patients were alive at the most recent review (April 1981), the results permit only cautious optimism.The improved remission rate in patients with acute myeloid leukemia3 4 5 6 has led to increasing demands on centers carrying out bone-marrow transplantation, but physicians who are considering the next step in treatment after . . .